The document provides brokerage reports from various firms on different companies:
- CLSA maintained a 'Neutral' rating on a company with a price target of Rs 1,210, noting petchem margins are weakening and weakness is expected to continue.
- Credit Suisse downgraded a company to 'Neutral' and cut its price target, citing macro slowdown will keep 2019-20 subdued and unlikely to see revenue/Ebtida growth for next 1-2 years.
- Axis Capital upgraded a company to 'Add' and hiked its price target, believing challenges will mitigate as earnings improve and transition has been managed well.